PILA — Pila Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK74.23m
- SEK70.98m
- SEK1.13m
Brief: Pila Pharma: Capital Infusion Via Convertible Loans
Brief: Pila Pharma Q2 Operating Loss Narrows To SEK 1.8 Mln
Brief: Pila Pharma Q1 EBIT Loss Narrows To SEK 1.8 Mln
Brief: Pila Pharma's CEO Increases Holding In Company
Brief: Pila Pharma Q3 EBIT Loss Narrows To SEK 2.3 Mln
Brief: Pila Pharma Completes 13-Week Safety Studies In Rats With No Adverse Signals In Dosing Phase
Brief: Pila Pharma Q2 Operating Loss SEK 2.3 Mln
Brief: Pila Pharma Candidate Molecule Receives Orphan Drug Designation In U.S.
Brief: Pila Pharma Q1 Rev Up At SEK 535 Mln
Brief: Pila Pharma Applies For Orphan Drug Designation In The USA
Brief: Pila Pharma Q4 EBIT Loss Widens To SEK 3.1 Mln
Brief: Pila Pharma Inks Deal With ERBC
Brief: Pila Pharma Q3 Operating Loss At SEK 3.2 million
Brief: Pila Pharma Receives GMP Certification Of Placebo Tablets